These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9750031)

  • 21. [High dose chemotherapy with autologous stem cell support in cancer patients].
    Abrahamsen JF; Kristoffersen EK; Hervig T; Ekanger R; Nesthus I; Ulvestad E
    Tidsskr Nor Laegeforen; 2000 May; 120(13):1523-8. PubMed ID: 10916472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose intensity and high dose therapy. Two different concepts.
    Livingston RB
    Cancer; 1994 Aug; 74(3 Suppl):1177-83. PubMed ID: 8039154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
    Stadtmauer EA; O'Neill A; Goldstein LJ; Crilley PA; Mangan KF; Ingle JN; Brodsky I; Martino S; Lazarus HM; Erban JK; Sickles C; Glick JH
    N Engl J Med; 2000 Apr; 342(15):1069-76. PubMed ID: 10760307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
    Yanovich S; Mitsky P; Cornetta K; Maziarz RT; Rosenfeld C; Krause DS; Lotz JP; Bitran JD; Williams S; Preti R; Somlo G; Burtness B; Mills B
    Bone Marrow Transplant; 2000 Jun; 25(11):1165-74. PubMed ID: 10849529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose therapy in breast cancer: out of favor but not out of promise.
    Glück S; Stewart D
    Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
    Demirer T; Buckner CD; Appelbaum FR; Clift R; Storb R; Myerson D; Lilleby K; Rowley S; Bensinger WI
    Bone Marrow Transplant; 1996 May; 17(5):769-74. PubMed ID: 8733696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic intensification and autotransplantation of hematopoietic stem cells in metastatic breast cancers].
    Lotz JP; Pène F; Bouleuc C; André T; Macovei C; Laadem A; Debourdeau P; Gumus Y; Merad Z; Avenin D; Esteso A; Bellaiche A; Izrael V
    Presse Med; 1996 Nov; 25(35):1737-43. PubMed ID: 8977588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
    Perkins JB; Effenbein GJ; Fields KK
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.
    Hensel M; Schneeweiss A; Sinn HP; Egerer G; Kornacker M; Solomayer E; Haas R; Bastert G; Ho AD
    Stem Cells; 2002; 20(1):32-40. PubMed ID: 11796920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose chemotherapy and stem-cell support in breast cancer.
    Pedrazzoli P; Da Prada GA; Robustelli della Cuna G
    Lancet; 1998 Oct; 352(9135):1220. PubMed ID: 9777858
    [No Abstract]   [Full Text] [Related]  

  • 31. Autologous bone marrow transplantation in the treatment of breast cancer: clinical and technologic strategies.
    Vaughan WP
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):55-8. PubMed ID: 8211216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome.
    Ahmed T; Kancherla R; Qureshi Z; Mittelman A; Seiter K; Mannancheril A; Puccio C; Chun HG; Bar M; Lipshutz M; Ali MF; Goldberg R; Preti R; Lake D; Durrani H; Farley T
    Bone Marrow Transplant; 2000 May; 25(10):1041-5. PubMed ID: 10828863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes.
    Bearman SI; Overmoyer BA; Bolwell BJ; Taylor CW; Shpall EJ; Cagnoni PJ; Mechling BE; Ronk B; Barón AE; Purdy MH; Ross M; Jones RB
    Bone Marrow Transplant; 1997 Dec; 20(11):931-7. PubMed ID: 9422471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose chemotherapy of breast cancer.
    Crown J; Raptis G; Hamilton N; Hudis C; Vahclat L; Fennelly D; Norton L
    Can J Oncol; 1995 Dec; 5 Suppl 1():80-2. PubMed ID: 8853530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer.
    Peters WP; Dansey RD; Klein JL; Baynes RD
    Oncologist; 2000; 5(1):1-13. PubMed ID: 10706643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
    Cheng YC; Rondón G; Yang Y; Smith TL; Gajewski JL; Donato ML; Shpall EJ; Jones R; Hortobagyi GN; Champlin RE; Ueno NT
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):794-804. PubMed ID: 15505610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer.
    Adkins D; Brown R; Trinkaus K; Maziarz R; Luedke S; Freytes C; Needles B; Wienski D; Fracasso P; Pluard T; Moriconi W; Ryan T; Hoelzer K; Safdar S; Rearden T; Rodriguez G; Khoury H; Vij R; DiPersio J
    J Clin Oncol; 1999 Jul; 17(7):2006-14. PubMed ID: 10561251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer studies yield mixed results on high-dose chemotherapy with stem cell support.
    Miller SL
    Am J Health Syst Pharm; 1999 May; 56(10):939. PubMed ID: 10365714
    [No Abstract]   [Full Text] [Related]  

  • 40. First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies.
    Naumann-Winter F; Greb A; Borchmann P; Bohlius J; Engert A; Schnell R
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD004626. PubMed ID: 23076906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.